Navigation Links
2013 BioProcess Theater Presentations Now Available on the BioProcess International Digital Media Website
Date:6/13/2013

New York, NY (PRWEB) June 13, 2013

BioProcess International (BPI) announces the online publication of the complete set of BPI Theater podcasts presented during the 2013 BIO International Convention, 22–25 April in Chicago, IL.

Now in its seventh year, the BioProcess Theater is a 50-seat amphitheater located at the heart of the BioProcess Zone in the BIO International Conference exhibit hall. The BPI Theater provides attendees with daily opportunities to listen, learn, and interact with leading experts as they present, discuss, and debate the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

BPI Theater podcast presentations include the following:

Biosimilars

  •     Pfenex and Agila Biotech Biosimilars Joint Venture: The Convergence of Expression and Manufacturing Technology Harnessing the Emerging Market Opportunity
  •     Developing and Manufacturing Biosimilars and Biobetters
  •     Biosimilars: Challenges and Solutions
  •     The Highs and Lows of Manufacturing a Biosimilar
  •     Biosimilar Development Concerns: Collaboration, Capacity, and CMOs

Single-Use Processing

  •     Purification and Concentration of Nanoparticles using Single-Use TFF
  •     Process Evolution from the Iron Age to the New Age: A Transition from a Stainless Steel and Glass to a Full Disposable Upstream Process
  •     Building and Operating a Single-Use Facility: Reducing Time, Cost, and Risk
  •     Flexible Facilities: Strategies for Supplying Complex Biologics in a Changing Global Market
  •     Accelerating BioProcess Development Using Microbioreactors
  •     Processing Biologics Using a Disposable Production Train?

Cell Therapy

  •     Defining Critical Parameters for Scale-Up and Process Control in Cell Therapy
  •     Leveraging a CMO to Optimize the Financial and Operational Efficiency of an Emerging Cell Therapy Business
  •     Case Study: Scale-Up Strategy for Liver Stem Cell Therapy
  •     Serum-Free Culture of Mesenchymal Stem Cells
  •     CGMP Compliance Trends for Cellular Therapeutics and the Challenges in Late-Stage Commercial Ready Manufacturing

Antibody/Non-Antibody Manufacturing

  •     Optimized Solutions for Better Biologic Treatments
  •     Case Study: The Effect of Upstream Process Changes on HCP Composition and Detection
  •     New Endotoxin Detection and Removal Methods in Downstream Processing of Biologics
  •     Bioconjugates – From Targets to Therapeutics

Vaccine Manufacturing

  •     Development of Protein Capsular Matrix Vaccine (PCMV) Platform Technology
  •     Simpler and More Efficient Vaccine Manufacturing
  •     In Silico and In Vitro tools for Accelerated Vaccine Design
  •     Five Traits of Successful Vaccine Development and Production

Featured presenters represent a broad range of companies throughout the global industrial biotherapeutic community including Advanced Bioscience Laboratories, Inc.; Agila Biotech; ATMI LifeSciences; Avid Bioservices, Inc.; BioGenes; BiogenIdec; BioProcess Technology Consultants; Boehringer Ingelheim; Boston Oncology; Catalent Pharma Solutions; Centrose; Cobra Biologics; Corning Life Sciences; Cytovance Biologics; EMD Millipore; Gallus BioPharmaceuticals, Inc.; GE Healthcare; Hospira; Hyglos, GmbH; ImClone Systems; ImmunoGen, Inc.; Latham Biopharm Group; Laureate Biopharma; Lonza; Lonza Custom Manufacturing; M&W Group; m2p Labs; Malaysian Bio-XCell Sdn Bhd; Matrivax Research and Development Corp.; PCT Cell Therapy Services; Pfenex; PolyPeptide Group; PolyTherics; Promethera Biosciences; Sanofi Pasteur, Spectrum Laboratories; Inc.; WuXi AppTec; and Xcellerex.

BPI Theater podcasts are available free online as part of the BioProcess International Digital Media website (http://www.bpidm.com/bpi-theater).

About BioProcess International

BioProcess International™ (http://www.bioprocessintl.com) is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.

BioProcess International™ is part of the IBC Life Sciences Division of Informa, plc, a leading international provider of specialist information and services for the academic, professional and business communities. Informa offers a world-class portfolio of publications, events and data services for researchers, students, lecturers and professionals in the academic and scientific communities worldwide.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10832281.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BioProcess International May 2013 Issue Published on the App Store Featuring App-only Exclusive Content
2. The Columbia Center for Theatrical Arts (CCTA) Announces Its Theater Program for Special Needs Youth
3. CABARET! Evening of Music, Songs and Laughter to Benefit Children's Theater
4. Maryland Children's Theater Holds Auditions for Summer Youth Productions of SHREK! and Les Misérables
5. Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy May 27th 7:00 PM
6. AAO-HNSF 2012 new poster presentations
7. Implicit race bias increases the differences in the neural representations of black and white faces
8. Automated autism screening tool available on Autism Speaks website
9. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
10. Polar RCX5 Tour de France Available At The Heart Rate Watch Company
11. IntelliQuote Works to Educate Consumers about the Importance of Life Insurance Protection and to Make Coverage More Readily Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: